Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 02:00 ET | Source: CoaguSense, Inc.

CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring

FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today...
January 28, 2026 10:36 ET | Source: Research and Markets

Bleeding Disorders Treatment Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Takeda Pharmaceutical Co., Roche, Novo Nordisk, Pfizer, Bayer and More

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Bleeding Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
November 10, 2025 09:00 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

PONTE VEDRA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in...
April 09, 2025 11:08 ET | Source: Research and Markets

Catastrophic Antiphospholipid Syndrome Market Research 2025-2034, Profiles of Abbott, AbbVie, Boehringer Ingelheim, BMS, Cadrenal, Eli Lily, F. Hoffmann-La Roche, J&J, Merck, Novartis, Pfizer, Sanofi

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Catastrophic Antiphospholipid Syndrome Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
April 03, 2023 11:05 ET | Source: SNS Insider pvt ltd

Anticoagulation Market to Touch USD 61.49 Billion by 2030 owing to Increasing Prevalence of Cardiovascular Diseases across the Globe | Research by SNS Insider

Pune, April 03, 2023 (GLOBE NEWSWIRE) -- As per the report by SNS Insider, the Anticoagulation Market had a worth of USD 35.25 billion in 2022, and is anticipated to attain USD 61.49 billion by...
March 26, 2020 12:00 ET | Source: The Joint Commission

Anticoagulation protocol reduces venous thromboembolisms in patients with traumatic brain injury

Study in April 2020 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., March 26, 2020 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) is one of the leading...
February 26, 2013 08:00 ET | Source: On-X Life Technologies Inc.

On-X LTI Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring

AUSTIN, Texas, Feb. 26, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the US Food & Drug Administration (FDA) to market the...
October 29, 2012 08:00 ET | Source: On-X Life Technologies Inc.

On-X LTI Launches Innovative Heart Valve Products at European Meeting in Barcelona

AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
October 22, 2012 08:01 ET | Source: On-X Life Technologies Inc.

On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve

If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
May 23, 2012 09:00 ET | Source: On-X Life Technologies Inc.

The On-X(R) Heart Valve Compares Favorably to Tissue Valves

AUSTIN, Texas, May 23, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that results from a study comparing the On-X mechanical heart valve to tissue valves...